Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model is a research paper published in Radiation Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P01-CA080124
NCI NIH HHS
Grant: P01 CA080124
National Institutes of Health
Grant: 1P01CA080124-01A1
Core--Bioengineering
National Institutes of Health
Grant: 5R01CA208205-03
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
National Institutes of Health
Grant: 5R35CA197743-05
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
FWCI
1.72
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model
Additional file 1 of Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model